• Citer

Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N1) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT).

par Loi, Sherene ;Salgado, Roberto;Piette, F;Sirtaine, Nicolas;Van Eenoo, Françoise;Kammler, R;Rouas, Ghizlane;Francis, P;Crown, John;Nordenskjöld, B;Gutierrez, J;Andersson, M;Vila, Mireia Margeli;Jakesz, Raimund;Viale, Giuseppe;Quinaux, E;Di Leo, Angelo ;Michiels, Stefan ;Sotiriou, Christos ;Piccart-Gebhart, Martine
Référence ASCO Annual Meeting (2011-06: Chicago, USA)
Publication Non publié, 2011-06

Poster de conférence

• Détails

Titre:	Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N1) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT).
Auteur:	Loi, Sherene; Salgado, Roberto; Piette, F; Sirtaine, Nicolas; Van Eenoo, Françoise; Kammler, R; Rouas, Ghizlane; Francis, P; Crown, John; Nordenskjöld, B; Gutierrez, J; Andersson, M; Vila, Mireia Margeli; Jakesz, Raimund; Viale, Giuseppe; Quinaux, E; Di Leo, Angelo; Michiels, Stefan; Sotiriou, Christos; Piccart-Gebhart, Martine
Informations sur la publication:	ASCO Annual Meeting (2011-06: Chicago, USA)
Statut de publication:	Non publié, 2011-06
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais